Controlling the gastrointestinal fate of nutraceutical and pharmaceutical-enriched lipid nanoparticles: From mixed micelles to chylomicrons

NanoImpact

Volumn 5, Issue , 2017, Pages 13-21

  Yao, Mingfei ^a,b   McClements, David Julian ^a   Zhao, Faqing ^c   Craig, Roger W ^c   Xiao, Hang ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b ZHEJIANG UNIVERSITY   (China)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Bioavailability; Caco 2 monolayer; Chylomicrons; Lipid nanoparticles; Mixed micelles; Nutraceuticals; Polymethoxyflavones

Indexed keywords

EID: 85007382328     PISSN: None     EISSN: 24520748     Source Type: Journal    
DOI: 10.1016/j.impact.2016.12.001     Document Type: Article

References (41)

1. Abeywardena, M.Y., Head, R.J., Longchain n − 3 polyunsaturated fatty acids and blood vessel function. Cardiovasc. Res. 52:3 (2001), 361–371.
2. Almgren, M., Mixed micelles and other structures in the solubilization of bilayer lipid membranes by surfactants. Biochim. Biophys. Acta 1508:1–2 (2000), 146–163.
3. Bateman, P.A., Jackson, K.G., Maitin, V., Yaqoob, P., Williams, C.M., Differences in cell morphology, lipid and apo B secretory capacity in Caco-2 cells following long term treatment with saturated and monounsaturated fatty acids. Biochim. Biophys. Acta 1771:4 (2007), 475–485.
4. Demignot, S., Beilstein, F., Morel, E., Triglyceride-rich lipoproteins and cytosolic lipid droplets in enterocytes: key players in intestinal physiology and metabolic disorders. Biochimie 96 (2014), 48–55.
5. Djousse, L., Arnett, D.K., Carr, J.J., Eckfeldt, J.H., Hopkins, P.N., Province, M.A., Ellison, C., Dietary linolenic acid is inversely associated with calcified atherosclerotic plaque in the coronary arteries - the National Heart, Lung, and Blood Institute family heart study. Circulation 111:22 (2005), 2921–2926.
6. Dong, P., Qiu, P., Zhu, Y., Li, S., Ho, C.T., McClements, D.J., Xiao, H., Simultaneous determination of four 5-hydroxy polymethoxyflavones by reversed-phase high performance liquid chromatography with electrochemical detection. J. Chromatogr. A 1217:5 (2010), 642–647.
7. Field, F.J., Albright, E., Mathur, S.N., Regulation of triglyceride-rich lipoprotein secretion by fatty acids in CaCo-2 cells. J. Lipid Res. 29:11 (1988), 1427–1437.
8. Gonnet, M., Lethuaut, L., Boury, F., New trends in encapsulation of liposoluble vitamins. J. Control. Release 146:3 (2010), 276–290.
9. Harris, W.S., Hustvedt, B.E., Hagen, E., Green, M.H., Lu, G., Drevon, C.A., n − 3 fatty acids and chylomicron metabolism in the rat. J. Lipid Res. 38:3 (1997), 503–515.
10. Holm, R., Mullertz, A., Christensen, E., Hoy, C.E., Kristensen, H.G., Comparison of total oral bioavailability and the lymphatic transport of halofantrine from three different unsaturated triglycerides in lymph-cannulated conscious rats. Eur. J. Pharm. Sci. 14:4 (2001), 331–337.
11. Israelachvili, J., Intermolecular and Surface Forces, Third Edition. third ed., 2011, Academic Press, London, UK.
12. Kobayashi, H., Watanabe, R., Choyke, P.L., Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target?. Theranostics 4:1 (2013), 81–89.
13. Leonard, M., Creed, E., Brayden, D., Baird, A.W., Evaluation of the Caco-2 monolayer as a model epithelium for iontophoretic transport. Pharm. Res. 17:10 (2000), 1181–1188.
14. Luchoomun, J., Hussain, M.M., Assembly and secretion of chylomicrons by differentiated Caco-2 cells - nascent triglycerides and preformed phospholipids are preferentially used for lipoprotein assembly. J. Biol. Chem. 274:28 (1999), 19565–19572.
15. McClements, D.J., Decker, E.A., Park, Y., Weiss, J., Structural design principles for delivery of bioactive components in nutraceuticals and functional foods. Crit. Rev. Food Sci. Nutr. 49:6 (2009), 577–606.
16. Mingfei Yao, J.C., Zheng, J., Mingyue, S., McClements, D.J., Xiao, H., Enhanced lymphatic transport of bioactive lipids: cell culture study of polymethoxyflavone incorporation into chylomicrons. Food Funct., 2013.
17. Mozaffarian, D., Wu, J.H., Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J. Am. Coll. Cardiol. 58:20 (2011), 2047–2067.
18. Mullertz, A., Fatouros, D.G., Smith, J.R., Vertzoni, M., Reppas, C., Insights into intermediate phases of human intestinal fluids visualized by atomic force microscopy and cryo-transmission electron microscopy ex vivo. Mol. Pharm. 9:2 (2012), 237–247.
19. Nelson, R., Oleic acid suppresses overexpression of ERBB2 oncogene. Lancet Oncol., 6(2), 2005, 69.
20. Ng, K.K., Lovell, J.F., Zheng, G., Lipoprotein-inspired nanoparticles for cancer theranostics. Acc. Chem. Res. 44:10 (2011), 1105–1113.
21. O'Driscoll, C.M., Lipid-based formulations for intestinal lymphatic delivery. Eur. J. Pharm. Sci. 15:5 (2002), 405–415.
22. Olofsson, S.O., Bostrom, P., Andersson, L., Rutberg, M., Perman, J., Boren, J., Lipid droplets as dynamic organelles connecting storage and efflux of lipids. Biochim. Biophys. Acta 1791:6 (2009), 448–458.
23. Porter, C.J., Charman, S.A., Charman, W.N., Lymphatic transport of halofantrine in the triple-cannulated anesthetized rat model: effect of lipid vehicle dispersion. J. Pharm. Sci. 85:4 (1996), 351–356.
24. Porter, C.J., Trevaskis, N.L., Charman, W.N., Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat. Rev. Drug Discov. 6:3 (2007), 231–248.
25. Qiu, P., Dong, P., Guan, H., Li, S., Ho, C.T., Pan, M.H., McClements, D.J., Xiao, H., Inhibitory effects of 5-hydroxy polymethoxyflavones on colon cancer cells. Mol. Nutr. Food Res. 54:Suppl. 2 (2010), S244–S252.
26. Qiu, P., Guan, H., Dong, P., Li, S., Ho, C.T., Pan, M.H., McClements, D.J., Xiao, H., The p53-, Bax- and p21-dependent inhibition of colon cancer cell growth by 5-hydroxy polymethoxyflavones. Mol. Nutr. Food Res. 55:4 (2011), 613–622.
27. Ranheim, T., Gedde-Dahl, A., Rustan, A.C., Drevon, C.A., Effect of chronic incubation of CaCo-2 cells with eicosapentaenoic acid (20:5, n − 3) and oleic acid (18:1, n − 9) on triacylglycerol production. Biochem. J. 303:Pt 1 (1994), 155–161.
28. Schmitz, G., R, V.F., Lipid droplets as dynamic organelles of fat deposition and release. Biochim. Biophys. Acta 1791:6 (2009), 397–398.
29. Shen, H., Howles, P., Tso, P., From interaction of lipidic vehicles with intestinal epithelial cell membranes to the formation and secretion of chylomicrons. Adv. Drug Deliv. Rev. 50:Suppl. 1 (2001), S103–S125.
30. Sun, M., Zhai, X., Xue, K., Hu, L., Yang, X., Li, G., Si, L., Intestinal absorption and intestinal lymphatic transport of sirolimus from self-microemulsifying drug delivery systems assessed using the single-pass intestinal perfusion (SPIP) technique and a chylomicron flow blocking approach: linear correlation with oral bioavailabilities in rats. Eur. J. Pharm. Sci. 43:3 (2011), 132–140.
31. Trevaskis, N.L., Charman, W.N., Porter, C.J., Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update. Adv. Drug Deliv. Rev. 60:6 (2008), 702–716.
32. van Greevenbroek, M.M., de Bruin, T.W., Chylomicron synthesis by intestinal cells in vitro and in vivo. Atherosclerosis 141:Suppl. 1 (1998), S9–16.
33. van Greevenbroek, M.M., van Meer, G., Erkelens, D.W., de Bruin, T.W., Effects of saturated, mono-, and polyunsaturated fatty acids on the secretion of apo B containing lipoproteins by Caco-2 cells. Atherosclerosis 121:1 (1996), 139–150.
34. Van Veld, P.A., Vetter, R.D., Lee, R.F., Patton, J.S., Dietary fat inhibits the intestinal metabolism of the carcinogen benzo[a]pyrene in fish. J. Lipid Res. 28:7 (1987), 810–817.
35. Vermeer, M.A., Mulder, T.P., Molhuizen, H.O., Theaflavins from black tea, especially theaflavin-3-gallate, reduce the incorporation of cholesterol into mixed micelles. J. Agric. Food Chem. 56:24 (2008), 12031–12036.
36. Wijendran, V., Hayes, K.C., Dietary n − 6 and n − 3 fatty acid balance and cardiovascular health. Annu. Rev. Nutr. 24 (2004), 597–615.
37. Williams, H.D., Trevaskis, N.L., Charman, S.A., Shanker, R.M., Charman, W.N., Pouton, C.W., Porter, C.J., Strategies to address low drug solubility in discovery and development. Pharmacol. Rev. 65:1 (2013), 315–499.
38. Yanez, J.A., Wang, S.W., Knemeyer, I.W., Wirth, M.A., Alton, K.B., Intestinal lymphatic transport for drug delivery. Adv. Drug Deliv. Rev. 63:10–11 (2011), 923–942.
39. Yeap, Y.Y., Trevaskis, N.L., Quach, T., Tso, P., Charman, W.N., Porter, C.J.H., Intestinal bile secretion promotes drug absorption from lipid colloidal phases via induction of supersaturation. Mol. Pharm. 10:5 (2013), 1874–1889.
40. Zheng, J., Song, M., Dong, P., Qiu, P., Guo, S., Zhong, Z., Li, S., Ho, C.T., Xiao, H., Identification of novel bioactive metabolites of 5-demethylnobiletin in mice. Mol. Nutr. Food Res. 57:11 (2013), 1999–2007.
41. Zheng, J.K., Bi, J.F., Johnson, D., Sun, Y., Song, M.Y., Qiu, P.J., Dong, P., Decker, E., Xiao, H., Analysis of 10 metabolites of polymethoxyflavones with high sensitivity by electrochemical detection in high-performance liquid chromatography. J. Agric. Food Chem. 63:2 (2015), 509–516.